A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan-Reference-Cited by-同舟云学术

A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan

Published:2016-03 Issue:3 Volume:140 Page:559-564
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Mizuno Mika^ORCID,Hiura Masamichi,Kikkawa Fumitaka,Numa Fumitaka,Yaegashi Nobuo,Narahara Hisashi,Aoki Daisuke,Kimura Eizo,Kato Hisamori,Shimokawa Mototsugu,Sugiyama Toru,Kamura Toshiharu

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. Nausea and emesis: still an unsolved problem in cancer patients?;Herrstedt;Support. Care Cancer,2002

2. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America;Poli-Bigelli;Cancer,2003

3. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

4. Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC). Ann Oncol. 1998;9:811–9.

5. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann. Oncol.,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials;Cancer Management and Research;2024-04

2. Visible light-driven photocatalytic sulfonative oxidation of benzyl secondary amines;Organic & Biomolecular Chemistry;2024

3. Minimal clinically important difference of the Functional Living Index‐Emesis in patients with gynecological malignant tumor: A post hoc analysis of a single‐arm study;Journal of Obstetrics and Gynaecology Research;2023-08-08

4. Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug;Current Oncology;2022-10-31

5. The efficacy of single dose palonosetron in highly emetogenic chemotherapy protocols compared to oral aprepitant and ondansetron;Journal of Pharmacovigilance and Drug Research;2022-09-01